CJC-1295
CJC-1295 is a long-acting growth hormone–releasing hormone (GHRH) analog peptide discussed in fitness stacks—often paired with ipamorelin.
CJC-1295 is a long-acting growth hormone–releasing hormone (GHRH) analog peptide discussed in fitness stacks—often paired with ipamorelin.
CJC-1295 is a long-acting growth hormone–releasing hormone (GHRH) analog peptide discussed in fitness stacks—often paired with ipamorelin. It is not an approved over-the-counter supplement. WADA prohibits many GH-related peptides; products sold as “research use only” are unregulated for human consumption.
In fitness and longevity forums, these names often refer to research chemicals—not supplements. Many are on WADA prohibited lists, lack OTC approval, and are not the same category as collagen powder or cosmetic serums.
Forum stacks combine a GHRH analog (CJC-1295) with a GH secretagogue (ipamorelin) under the theory of synergistic GH release. That combination is not a validated medical protocol for healthy adults and carries anti-doping and safety risks.
CJC-1295 is a long-acting growth hormone–releasing hormone (GHRH) analog peptide discussed in fitness stacks—often paired with ipamorelin. It is not an approved over-the-counter supplement. WADA prohibits many GH-related peptides; products sold as “research use only” are unregulated for human consumption.
Many peptides discussed in fitness communities are WADA-prohibited or unapproved for OTC use. Athletes should verify current WADA lists and consult an anti-doping advisor—not a supplement label.